|
SNN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.04919999999831E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.437280E-04 |
| Normal-vs-Stage2 |
3.065400E-01 |
| Normal-vs-Stage3 |
4.32779999615107E-08 |
| Normal-vs-Stage4 |
4.696099999979E-06 |
| Stage1-vs-Stage2 |
4.262300E-03 |
| Stage1-vs-Stage3 |
2.072300E-02 |
| Stage1-vs-Stage4 |
5.998300E-02 |
| Stage2-vs-Stage3 |
1.605350E-04 |
| Stage2-vs-Stage4 |
2.956500E-04 |
| Stage3-vs-Stage4 |
9.516600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.15179999996096E-06 |
| Normal-vs-AfricanAmerican |
3.955500E-04 |
| Normal-vs-Asian |
2.371000E-04 |
| Caucasian-vs-AfricanAmerican |
6.166400E-01 |
| Caucasian-vs-Asian |
6.261400E-01 |
| AfricanAmerican-vs-Asian |
8.867400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.964200E-03 |
| Normal-vs-Female |
2.21939999999199E-05 |
| Male-vs-Female |
8.912800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.79020000000386E-05 |
| Normal-vs-Age(41-60Yrs) |
8.3714000000068E-05 |
| Normal-vs-Age(61-80Yrs) |
1.036320E-02 |
| Normal-vs-Age(81-100Yrs) |
3.198400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.516000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.587600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.921800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.423200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.400600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.686600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.814700E-04 |
| Classical-VS-Follicular |
1.6379999999705E-06 |
| Classical-VS-Other |
9.362000E-01 |
| Classical-VS-Normal |
1.0228000002499E-07 |
| Tall-VS-Follicular |
2.8347002523077E-10 |
| Tall-VS-Other |
2.873800E-01 |
| Tall-VS-Normal |
4.31890079255481E-11 |
| Follicular-VS-Other |
1.245020E-01 |
| Follicular-VS-Normal |
1.928970E-01 |
| Other-VS-Normal |
2.358200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.799600E-02 |
| Normal-vs-N1 |
4.77307082746847E-12 |
| N0-vs-N1 |
2.33260000204183E-08 |
|
|
